Russia’s consumer health watchdog Rospotrebnadzor on January 19 told TASS news agency that Russia’s second Covid-19 vaccine EpiVacCorona proved 100% effective in early-stage trials.

EpiVacCorona has become the second COVID-19 vaccine candidate to get regulatory approval in Russia after Sputnik V. Here are some key things about the vaccine.